BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29082496)

  • 1. High Content Imaging Assays for IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines.
    Johnston PA; Sen M; Hua Y; Camarco DP; Shun TY; Lazo JS; Grandis JR
    Methods Mol Biol; 2018; 1683():229-244. PubMed ID: 29082496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.
    Johnston PA; Sen M; Hua Y; Camarco D; Shun TY; Lazo JS; Grandis JR
    Assay Drug Dev Technol; 2014; 12(1):55-79. PubMed ID: 24127660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines.
    Johnston PA; Sen M; Hua Y; Camarco DP; Shun TY; Lazo JS; Wilson GM; Resnick LO; LaPorte MG; Wipf P; Huryn DM; Grandis JR
    Assay Drug Dev Technol; 2015 Sep; 13(7):356-76. PubMed ID: 26317883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
    Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
    Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma.
    Ouédraogo ZG; Müller-Barthélémy M; Kemeny JL; Dedieu V; Biau J; Khalil T; Raoelfils LI; Granzotto A; Pereira B; Beaudoin C; Guissou IP; Berger M; Morel L; Chautard E; Verrelle P
    Brain Pathol; 2016 Jan; 26(1):18-30. PubMed ID: 25736961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.
    Peyser ND; Pendleton K; Gooding WE; Lui VW; Johnson DE; Grandis JR
    PLoS One; 2016; 11(11):e0166185. PubMed ID: 27855189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and utilization of activated STAT3 detection assays for screening a library of secreted proteins.
    Fursov N; Gates IV; Panavas T; Giles-Komar J; Powers G
    Assay Drug Dev Technol; 2011 Aug; 9(4):420-9. PubMed ID: 21294636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma.
    Rodrigues BR; Queiroz-Hazarbassanov N; Lopes MH; Bleggi-Torres LF; Suzuki S; Cunha IW; Sanematsu P; Martins VR
    Pathol Res Pract; 2016 Jun; 212(6):517-23. PubMed ID: 27013058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin Induces Phosphorylation of Distinct Residues of Signal Transducer and Activator of Transcription 3 (STAT3) via Different Signaling Pathways.
    Corsetti G; Yuan Z; Romano C; Chen-Scarabelli C; Fanzani A; Pasini E; Dioguardi FS; Onorati F; Linardi D; Knight R; Patel H; Faggian G; Saravolatz L; Scarabelli TM
    Med Sci Monit Basic Res; 2019 May; 25():139-152. PubMed ID: 31073117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma.
    Lesinski GB; Nannapaneni S; Griffith CC; Patel M; Chen W; Chen Z; Ahmed R; Wieland A; Shin DM; Chen ZG; Saba NF
    Head Neck Pathol; 2019 Sep; 13(3):304-312. PubMed ID: 30191505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
    Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
    Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
    Guo YQ; Lu P; Duan ZF; Zhang Z
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer.
    Berishaj M; Gao SP; Ahmed S; Leslie K; Al-Ahmadie H; Gerald WL; Bornmann W; Bromberg JF
    Breast Cancer Res; 2007; 9(3):R32. PubMed ID: 17531096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-apoptotic effect of interleukin-22 on fibroblast-like synoviocytes in patients with rheumatoid arthritis is mediated via the signal transducer and activator of transcription 3 signaling pathway.
    Zhao M; Li Y; Xiao W
    Int J Rheum Dis; 2017 Feb; 20(2):214-224. PubMed ID: 27493089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
    Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
    J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.
    Qin HR; Kim HJ; Kim JY; Hurt EM; Klarmann GJ; Kawasaki BT; Duhagon Serrat MA; Farrar WL
    Cancer Res; 2008 Oct; 68(19):7736-41. PubMed ID: 18829527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
    Ray S; Boldogh I; Brasier AR
    Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation.
    Leslie K; Gao SP; Berishaj M; Podsypanina K; Ho H; Ivashkiv L; Bromberg J
    Breast Cancer Res; 2010; 12(5):R80. PubMed ID: 20929542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.
    Lapeire L; Hendrix A; Lambein K; Van Bockstal M; Braems G; Van Den Broecke R; Limame R; Mestdagh P; Vandesompele J; Vanhove C; Maynard D; Lehuédé C; Muller C; Valet P; Gespach CP; Bracke M; Cocquyt V; Denys H; De Wever O
    Cancer Res; 2014 Dec; 74(23):6806-19. PubMed ID: 25252914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
    Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
    J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.